• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立和验证高通量类器官药物筛选平台的方法。

Assay establishment and validation of a high-throughput organoid-based drug screening platform.

机构信息

Institute of Radiation Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, China.

D1 Medical Technology Company, Shanghai, 201802, China.

出版信息

Stem Cell Res Ther. 2022 May 26;13(1):219. doi: 10.1186/s13287-022-02902-3.

DOI:10.1186/s13287-022-02902-3
PMID:35619149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9137096/
Abstract

BACKGROUND

Organoids are three-dimensional structures that closely recapitulate tissue architecture and cellular composition, thereby holding great promise for organoid-based drug screening. Although growing in three-dimensional provides the possibility for organoids to recapitulate main features of corresponding tissues, it makes it incommodious for imaging organoids in two-dimensional and identifying surviving organoids from surrounding dead cells after organoids being treated by irradiation or chemotherapy. Therefore, significant work remains to establish high-quality controls to standardize organoid analyses and make organoid models more reproducible.

METHODS

In this study, the Z-stack imaging technique was used for the imaging of three-dimensional organoids to gather all the organoids' maximum cross sections in one imaging. The combination of live cell staining fluorescent dye Calcein-AM and ImageJ assessment was used to analyze the survival of organoids treated by irradiation or chemotherapy.

RESULTS

We have established a novel quantitative high-throughput imaging assay that harnesses the scalability of organoid cultures. Using this assay, we can capture organoid growth over time, measure multiple whole-well organoid readouts, and show the different responses to drug treatments.

CONCLUSIONS

In summary, combining the Z-stack imaging technique and fluorescent labeling methods, we established an assay for the imaging and analysis of three-dimensional organoids. Our data demonstrated the feasibility of using organoid-based platforms for high-throughput drug screening assays.

摘要

背景

类器官是一种能够高度重现组织架构和细胞组成的三维结构,因此在基于类器官的药物筛选中具有广阔的应用前景。尽管在三维环境中生长为类器官重现相应组织的主要特征提供了可能性,但这使得在二维环境中对类器官进行成像以及在类器官受到辐射或化学疗法处理后,从周围死亡细胞中识别存活的类器官变得很不方便。因此,仍然需要开展大量工作来建立高质量的对照,以规范类器官分析并使类器官模型更具可重复性。

方法

在这项研究中,我们使用 Z -stack 成像技术对三维类器官进行成像,以在一次成像中获取所有类器官的最大横截面。活细胞染色荧光染料 Calcein-AM 与 ImageJ 评估的结合用于分析辐射或化学疗法处理后的类器官的存活情况。

结果

我们建立了一种新颖的定量高通量成像测定法,利用类器官培养的可扩展性。使用该测定法,我们可以捕获类器官随时间的生长情况,测量整个孔板的多个类器官读数,并展示对药物治疗的不同反应。

结论

总之,我们结合 Z-stack 成像技术和荧光标记方法,建立了一种用于三维类器官成像和分析的测定法。我们的数据证明了基于类器官的平台在高通量药物筛选测定中的可行性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/9137096/43a3f3aa6f40/13287_2022_2902_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/9137096/422b396c9b12/13287_2022_2902_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/9137096/90f13a28e47a/13287_2022_2902_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/9137096/57bcd64ead42/13287_2022_2902_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/9137096/4094fa528953/13287_2022_2902_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/9137096/f5aef6e1d783/13287_2022_2902_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/9137096/410030507913/13287_2022_2902_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/9137096/43a3f3aa6f40/13287_2022_2902_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/9137096/422b396c9b12/13287_2022_2902_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/9137096/90f13a28e47a/13287_2022_2902_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/9137096/57bcd64ead42/13287_2022_2902_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/9137096/4094fa528953/13287_2022_2902_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/9137096/f5aef6e1d783/13287_2022_2902_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/9137096/410030507913/13287_2022_2902_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3963/9137096/43a3f3aa6f40/13287_2022_2902_Fig7_HTML.jpg

相似文献

1
Assay establishment and validation of a high-throughput organoid-based drug screening platform.建立和验证高通量类器官药物筛选平台的方法。
Stem Cell Res Ther. 2022 May 26;13(1):219. doi: 10.1186/s13287-022-02902-3.
2
High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids.高通量成像分析方法用于 3D 前列腺癌类器官的药物筛选。
SLAS Discov. 2021 Oct;26(9):1107-1124. doi: 10.1177/24725552211020668. Epub 2021 Jun 11.
3
Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening.开发微型 3D 类器官培养平台,用于超高通量筛选。
J Mol Cell Biol. 2020 Aug 1;12(8):630-643. doi: 10.1093/jmcb/mjaa036.
4
A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.一种全自动高通量工作流程,用于基于 3D 的人类中脑细胞类器官中的化学筛选。
Elife. 2020 Nov 3;9:e52904. doi: 10.7554/eLife.52904.
5
Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures.用于三维患者来源的结肠癌类器官培养的高通量筛选平台的检测方法建立与验证
J Biomol Screen. 2016 Oct;21(9):931-41. doi: 10.1177/1087057116650965. Epub 2016 May 27.
6
High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell-Derived Organoids.使用人多能干细胞衍生类器官进行高逼真度药物性肝损伤筛选。
Gastroenterology. 2021 Feb;160(3):831-846.e10. doi: 10.1053/j.gastro.2020.10.002. Epub 2020 Oct 8.
7
OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening.OrBITS:用于先进药物筛选的患者来源类器官的无标记和延时监测。
Cell Oncol (Dordr). 2023 Apr;46(2):299-314. doi: 10.1007/s13402-022-00750-0. Epub 2022 Dec 12.
8
The Emerging Role of Neuronal Organoid Models in Drug Discovery: Potential Applications and Hurdles to Implementation.神经类器官模型在药物发现中的新兴作用:潜在应用及实施障碍。
Mol Pharmacol. 2021 Apr;99(4):256-265. doi: 10.1124/molpharm.120.000142. Epub 2021 Feb 5.
9
OrganoIDNet: a deep learning tool for identification of therapeutic effects in PDAC organoid-PBMC co-cultures from time-resolved imaging data.OrganoIDNet:一种用于从时间分辨成像数据中识别胰腺导管腺癌类器官与外周血单核细胞共培养物中治疗效果的深度学习工具。
Cell Oncol (Dordr). 2025 Feb;48(1):101-122. doi: 10.1007/s13402-024-00958-2. Epub 2024 May 28.
10
High-throughput organo-on-pillar (high-TOP) array system for three-dimensional ex vivo drug testing.高通量器官柱上(high-TOP)阵列系统用于三维离体药物测试。
Biomaterials. 2023 May;296:122087. doi: 10.1016/j.biomaterials.2023.122087. Epub 2023 Mar 7.

引用本文的文献

1
From 2D to 3D and beyond: the evolution and impact of in vitro tumor models in cancer research.从二维到三维及更深入:体外肿瘤模型在癌症研究中的演变与影响。
Nat Methods. 2025 Jul 25. doi: 10.1038/s41592-025-02769-1.
2
Precision medicine research progress based on colorectal cancer organoids.基于结直肠癌类器官的精准医学研究进展
Discov Oncol. 2025 Jun 23;16(1):1181. doi: 10.1007/s12672-025-02959-5.
3
A critical review on and models for the investigation of infection.关于感染调查的[具体内容]和模型的批判性综述。 (原文中“and”前后内容缺失,翻译可能不太准确,完整准确翻译需补充完整原文信息)

本文引用的文献

1
High-throughput formation and image-based analysis of basal-in mammary organoids in 384-well plates.在 384 孔板中高通量形成和基于图像的基底细胞型乳腺类器官分析。
Sci Rep. 2022 Jan 10;12(1):317. doi: 10.1038/s41598-021-03739-1.
2
Intestinal multicellular organoids to study colorectal cancer.肠细胞微器官用于结直肠癌研究。
Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188586. doi: 10.1016/j.bbcan.2021.188586. Epub 2021 Jun 30.
3
Automated evaluation of tumor spheroid behavior in 3D culture using deep learning-based recognition.
Front Cell Infect Microbiol. 2025 May 14;15:1516237. doi: 10.3389/fcimb.2025.1516237. eCollection 2025.
4
Advances and applications of gut organoids: modeling intestinal diseases and therapeutic development.肠道类器官的进展与应用:模拟肠道疾病及治疗开发
Life Med. 2025 Mar 7;4(2):lnaf012. doi: 10.1093/lifemedi/lnaf012. eCollection 2025 Apr.
5
Optimizing drug sensitivity assays in patient-derived tumor organoids: a comparison of IC50 estimation methods and experimental parameters.优化患者来源的肿瘤类器官中的药物敏感性测定:IC50估计方法和实验参数的比较
Biol Methods Protoc. 2025 Feb 13;10(1):bpaf012. doi: 10.1093/biomethods/bpaf012. eCollection 2025.
6
Application of an Integrated Single-Cell and Three-Dimensional Spheroid Culture Platform for Investigating Drug Resistance Heterogeneity and Epithelial-Mesenchymal Transition (EMT) in Lung Cancer Subclones.一种整合的单细胞和三维球体培养平台在研究肺癌亚克隆中的耐药异质性和上皮-间质转化(EMT)中的应用
Int J Mol Sci. 2025 Feb 19;26(4):1766. doi: 10.3390/ijms26041766.
7
Patient-Derived Tumor Organoids: A Platform for Precision Therapy of Colorectal Cancer.患者来源的肿瘤类器官:结直肠癌精准治疗的一个平台
Cell Transplant. 2025 Jan-Dec;34:9636897251314645. doi: 10.1177/09636897251314645.
8
Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method.促进肿瘤基质靶向治疗:模型难点与共培养类器官方法
Pharmaceuticals (Basel). 2025 Jan 8;18(1):62. doi: 10.3390/ph18010062.
9
6-Shogaol Derived from Ginger Inhibits Intestinal Crypt Stem Cell Differentiation and Contributes to Irritable Bowel Syndrome Risk.源自生姜的6-姜烯酚抑制肠道隐窝干细胞分化并增加肠易激综合征风险。
Research (Wash D C). 2024 Nov 7;7:0524. doi: 10.34133/research.0524. eCollection 2024.
10
Neuropilin-2-expressing breast cancer cells mitigate radiation-induced oxidative stress through nitric oxide signaling.神经纤毛蛋白-2 表达的乳腺癌细胞通过一氧化氮信号减轻辐射诱导的氧化应激。
J Clin Invest. 2024 Oct 1;134(22):e181368. doi: 10.1172/JCI181368.
基于深度学习的识别技术在 3D 培养中自动评估肿瘤球体行为。
Biomaterials. 2021 May;272:120770. doi: 10.1016/j.biomaterials.2021.120770. Epub 2021 Mar 22.
4
CBP/P300 Inhibitors Mitigate Radiation-Induced GI Syndrome by Promoting Intestinal Stem Cell-Mediated Crypt Regeneration.CBP/P300 抑制剂通过促进肠干细胞介导的隐窝再生来减轻辐射诱导的胃肠道综合征。
Int J Radiat Oncol Biol Phys. 2021 Jul 15;110(4):1210-1221. doi: 10.1016/j.ijrobp.2021.01.046. Epub 2021 Feb 3.
5
An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity.具有器官间均一性和患者间异质性的自动化类器官平台。
Cell Rep Med. 2020 Dec 22;1(9):100161. doi: 10.1016/j.xcrm.2020.100161.
6
SIRT1 inhibitors mitigate radiation-induced GI syndrome by enhancing intestinal-stem-cell survival.SIRT1 抑制剂通过增强肠干细胞的存活来减轻放射性胃肠综合征。
Cancer Lett. 2021 Mar 31;501:20-30. doi: 10.1016/j.canlet.2020.12.034. Epub 2020 Dec 24.
7
A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.一种全自动高通量工作流程,用于基于 3D 的人类中脑细胞类器官中的化学筛选。
Elife. 2020 Nov 3;9:e52904. doi: 10.7554/eLife.52904.
8
Organoid based personalized medicine: from bench to bedside.基于类器官的个性化医疗:从实验室到临床应用
Cell Regen. 2020 Nov 2;9(1):21. doi: 10.1186/s13619-020-00059-z.
9
BRCA1 and BRCA2 associated breast cancer and the roles of current modelling systems in drug discovery.BRCA1 和 BRCA2 相关性乳腺癌以及当前建模系统在药物发现中的作用。
Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188459. doi: 10.1016/j.bbcan.2020.188459. Epub 2020 Oct 29.
10
Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids.用于肿瘤类器官的动态和组合药物筛选的自动化微流控平台。
Nat Commun. 2020 Oct 19;11(1):5271. doi: 10.1038/s41467-020-19058-4.